Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve The meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 29th July, 2025 inter-alia, to consider and approve the following: 1. The Unaudited Financial Results (Standalone & Consolidation basis) of the Company for the quarter ending on 30th June, 2025 in accordance with Regulation 33 of the SEBI Listing Regulation. 2. Any other matter with the permission of the chair.

pdf

Eiko Lifesciences Ltd.

11 Jul 2025

55.69

0.91%

Company Update

Eiko Lifesciences Ltd - 540204 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and participants) Regulation, 2018 for quarter ended 30th June 2025.

pdf

Eiko Lifesciences Ltd.

04 Jul 2025

55.69

0.91%

Company Update

Eiko Lifesciences Ltd - 540204 - Clarification On Price Movement

BSE India

Please refer to your Email dated 04th July, 2025 regarding clarification on price movement. In this connection company wishes to inform that it has no role tio play in the price movement and that the market forces are the deciding factor for the same.

pdf

Eiko Lifesciences Ltd.

04 Jul 2025

55.69

0.91%

Company Update

Eiko Lifesciences Ltd - 540204 - Clarification sought from Eiko Lifesciences Ltd

BSE India

The Exchange has sought clarification from Eiko Lifesciences Ltd on July 4, 2025, with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Eiko Lifesciences Ltd.

26 Jun 2025

55.69

0.91%

SAST

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Kabra

pdf

Is Narendra Investments (Delhi) Ltd. worth buying?

11 Votes:

Buy 54.55%

Sell 27.27%

Hold 18.18%